-
Enhancing Targeted Literature Reviews (TLRs) with Artificial Intelligence (AI): A Methodological Approach for Conducting Efficient Targeted Searches
Sep 9, 2025, 16:22 PM -
Cost per Responder Analysis of Certolizumab Pegol vs. Adalimumab in Patients With Moderate to Severe Active Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Payer Perspective From France, Germany, Italy, and United Kingdom
Sep 9, 2025, 16:22 PM -
Transforming Patient Journeys With Agentic AI
Sep 9, 2025, 16:22 PM -
Persistence of Anticholinergic Agents in Patients With Overactive Bladder: A Cohort Study From the French National Health Insurance Claim Database (SNDS)
Sep 9, 2025, 16:22 PM -
Direct and Indirect Economic Burden Due to Chronic Limb-Threatening Ischemia (CLTI) in Germany
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Belatacept as Conversion Therapy in the Management of Patients Living With a Renal Graft in France
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review to Identify Risk Factors and Symptoms of Long COVID-19 in Adult Indian Patients
Sep 9, 2025, 16:22 PM -
Shifts in the French HTA Transparency Committee’s Use of Indirect Comparisons: Insights From a Systematic Review of the French Transparency Committee (TC) Opinions
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of Biosimilars in Europe: A Cost Analysis of Infliximab, Trastuzumab, and Rituximab
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
Sep 9, 2025, 16:22 PM -
Feasibility Evaluation of Claims Database: Best Practices and Case Study for a Comparative Analysis of Robotic-Assisted Colorectal Surgery in Germany
Sep 9, 2025, 16:22 PM -
Modeling What Matters: The Real-World Burden of Pregnancy-Related Complications in cTTP
Sep 9, 2025, 16:22 PM -
Semaglutide Weight Outcomes Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Real-World Setting
Sep 9, 2025, 16:22 PM -
Evaluating the Budget Impact of Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) in Patients With Moderate to Severe Asthma in the Saudi Healthcare System
Sep 9, 2025, 16:22 PM -
Real-World Associations Between Smoking Status and Genetic Driver Mutations in Metastatic Lung Cancer in US Community Oncology
Sep 9, 2025, 16:22 PM -
A Long and Winding Road: An Evaluation of NICE HST Appraisals Taking Longer Than Two Years for Guidance Publication
Sep 9, 2025, 16:22 PM -
Streamlining Cancer Treatment Pathways: Organizational Responses to Rising Chemotherapy Volumes
Sep 9, 2025, 16:22 PM -
Bimekizumab Improves Work Productivity in Patients With Hidradenitis Suppurativa: 2-Year Results From BE HEARD EXT
Sep 9, 2025, 16:22 PM -
Early Diagnosis and Treatment Optimization in Heart Failure Through NT-proBNP Testing in Primary and Specialist Care
Sep 9, 2025, 16:22 PM -
Inpatient Burden of Influenza and Influenza-Like Illness Among Adults Aged 60 and Older in Germany 2019-2024
Sep 9, 2025, 16:22 PM
